Candida Overgrowth and Gut Bacteria May Play a Role in ADHD, Early Research Suggests

Something unusual is showing up in the guts of children with ADHD, and it goes beyond the bacteria researchers usually track. A 2026 narrative review published in Microbiology Research by Veroslava Stanković, Dragana Jović, and Nataša Rančić synthesizes a growing body of preliminary evidence linking both bacterial and fungal dysbiosis to ADHD pathophysiology. The findings are exploratory and non-causal, but they open a credible scientific conversation about whether the gut microbiome is a genuine player in the neurodevelopmental disorder, not just a bystander.

Altered Gut Bacteria and Candida Overgrowth in Children with ADHD

The review draws together evidence from multiple lines of inquiry. On the bacterial side, specific genera show altered abundances in children with ADHD compared to controls: Faecalibacterium, Blautia, Odoribacter, and Enterococcus all appear to shift. These are not trivial organisms. Faecalibacterium prausnitzii, for instance, is one of the most abundant butyrate producers in a healthy colon, and reduced levels are associated with inflammatory conditions.

The fungal picture is arguably even more striking, and far less studied. Prior work cited in the review found that children with ADHD show a higher relative abundance of Ascomycota and lower Basidiomycota at the phylum level. More specifically, a study tracking Candida in ADHD patients found a significantly higher abundance of Candida albicans in children with ADHD compared to healthy controls. In laboratory conditions, secretions from C. albicans increased the permeability of intestinal epithelial cells, a finding that points toward a plausible mechanism rather than just a correlation.

Meanwhile, broader reviews of gut microbiota composition in ADHD confirm that differences exist at both community and taxon levels, though microbial diversity findings remain inconsistent across studies. The field has not converged on a single ADHD-specific microbial signature, and the 2026 review does not claim otherwise.

Why Intestinal Permeability Could Matter for Brain Function

The biological logic connecting a leaky gut to a neurodevelopmental disorder runs roughly as follows. When Candida albicans disrupts epithelial barrier integrity, it raises intestinal permeability. That increased permeability can allow microbial antigens and inflammatory mediators to pass into systemic circulation, promoting immune activation. From there, the hypothesis goes, those signals could influence central nervous system function through immune and neuroendocrine pathways.

This is not a new idea in neuroscience, but its application to ADHD specifically remains early-stage. The review frames bacterial and fungal dysbiosis as biologically plausible, primarily associative components of ADHD-related pathophysiology. That is careful language, and it should be. No controlled trial has yet demonstrated that correcting fungal dysbiosis improves ADHD symptoms. What researchers have is a set of associations that are coherent enough to warrant serious follow-up.

For the roughly 5 to 10 percent of school-aged children who carry an ADHD diagnosis globally, the stakes of getting this right are meaningful. Adults with ADHD consistently report lower quality of life compared to neurotypical peers, and pharmacological treatments, while effective for many, do not help everyone and come with their own side-effect profiles. Any complementary biological lever that could improve outcomes deserves investigation.

How Diet and Micronutrient Status Feed Into the Pathway

The review also addresses dietary quality as a modulator of the microbiota-gut-brain axis. This is not surprising: diet is the primary driver of gut microbial composition, and children with ADHD are known to have dietary patterns that skew toward processed foods and away from fiber-rich, micronutrient-dense options. The authors frame dietary quality and micronutrient status as upstream variables that shape which microbes thrive, including whether Candida populations expand.

This creates a compounding picture. A child eating a low-fiber, high-sugar diet may be inadvertently selecting for Candida overgrowth, which in turn may raise intestinal permeability, which may amplify inflammatory signaling that influences attention and behavior. Each link in that chain is individually supported by evidence, but the full sequence in humans with ADHD has not been demonstrated in a controlled study. The review is careful not to overstate the chain.

Probiotics and Synbiotics as Potential Interventions

Probiotics and synbiotics (combinations of probiotics and prebiotics) receive dedicated attention in the review as potential microbiome-targeted interventions. The authors recommend these as complementary strategies, particularly for patients who show gastrointestinal, dietary, immune, or metabolic vulnerability.

The evidence base here is mixed. A systematic review of prebiotics, probiotics, and synbiotics in ADHD found that Lactobacillus rhamnosus GG supplementation was associated with improved emotional, physical, social, and school functioning in some studies, though other trials showed contradictory results. On the more cautious end, a meta-analysis of seven randomized controlled trials involving 342 participants found no significant improvement in ADHD symptoms, including inattention or hyperactivity, with probiotic supplementation compared to placebo.

That null finding does not necessarily close the door. Most probiotic trials in ADHD have not specifically targeted fungal dysbiosis, have not selected participants based on microbiome profiles, and have used generic probiotic formulations rather than strains tailored to the observed imbalances. The field may need to move toward stratified, biomarker-guided trials before clearer signals emerge.

Open Questions About Mycobiome Research and Study Design

The fungal component of the gut microbiome in ADHD remains, in the authors' own framing, insufficiently investigated. Most gut microbiome studies in ADHD have focused on bacteria, using 16S rRNA sequencing that does not capture fungi at all. The mycobiome requires different sequencing approaches, and those studies are sparse.

Limitations in ADHD microbiome research more broadly include diverse study designs, small patient cohorts, varied age groups, differing medication statuses, gender imbalances, and heterogeneous analysis technologies. These methodological gaps mean that even the bacterial findings are difficult to replicate consistently, let alone the fungal ones. The review calls for larger, more standardized studies with genetic host information included.

The honest takeaway from this narrative review is that the gut-brain axis in ADHD is a scientifically legitimate area of inquiry, and the fungal angle deserves more resources than it has received. The associations between Candida overgrowth, increased intestinal permeability, immune activation, and ADHD symptoms form a biologically coherent hypothesis. But hypothesis is the right word for now. Until controlled interventional trials test whether correcting fungal or bacterial dysbiosis meaningfully shifts ADHD outcomes, clinicians and patients should treat microbiome-targeted strategies as adjuncts, not alternatives, to established care.

Evidence rating

INVESTIGATIONAL — 69/100

Caveats:

• This is a narrative review, not an original study — it synthesizes existing literature without meta-analytic pooling, so results reflect the heterogeneity of the underlying evidence.
• All associations between gut microbiome composition and ADHD are observational; causation has not been established.
• The fungal (mycobiome) component of this research area is early-stage and understudied — findings on Candida in ADHD are preliminary.
• Probiotics and dietary interventions discussed here are framed as complementary only; no intervention has been validated as a treatment for ADHD.
• Funding was not disclosed by the authors.

Narrative review synthesizing observational and mechanistic studies on gut bacterial and fungal dysbiosis in ADHD; no primary data are collected. Findings across included studies are heterogeneous and do not establish a consistent microbial signature or causal pathway. Evidence is preliminary and associative, and the mycobiome component of this literature remains sparsely studied and unreplicated at scale.

References

1. Veroslava V. Stankovic, Dragana P. Jovic, Natasa K. Rancic (2026). Fungal and Bacterial Dysbiosis in Attention-Deficit/Hyperactivity Disorder: Implications for Candida, Diet, Probiotics, and Quality of Life—A Narrative Review. Microbiology Research. https://doi.org/10.3390/microbiolres17070124
2. Liang‐Jen Wang, Sung‐Chou Li, Yuan‐Ming Yeh, Sheng‐Yu Lee, Ho‐Chang Kuo, Chia‐Yu Yang (2023). Gut mycobiome dysbiosis and its impact on intestinal permeability in attention‐deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/jcpp.13779
3. Yang Liu, Panpan Zhang, Hao Sun (2025). A narrative review of research advances in gut microbiota and microecological agents in children with attention deficit hyperactivity disorder (ADHD). Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1588135
4. The Quality of Life of Adults with Attention Deficit Hyperactivity Disorder – PMC – NIH. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909164/
5. A systematic review of the beneficial effects of prebiotics, probiotics, and synbiotics on ADHD – PMC. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395522/
6. Meta-analysis Finds Probiotics Have No Discernable Effect on ADHD Symptoms in Children and Adolescents. academic.oup.com. https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhya022/7633282
7. Andreas Hiergeist, Jana Gessner, André Gessner (2020). Current Limitations for the Assessment of the Role of the Gut Microbiome for Attention Deficit Hyperactivity Disorder (ADHD). Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2020.00623